2026-07-182 min
GHRP-6: Small-Study Statistics and Evidence Boundaries
An evidence-led GHRP-6 review focused on small-study statistics, human-study limits, regulatory context and claim verification.
Reviewed by Endocrine Evidence DeskEditorial desk
Endocrine Evidence Desk
Endocrine Research EditorsThe Endocrine Evidence Desk reviews GH, GHRH, IGF-1 and ghrelin-receptor mechanisms using primary research and regulatory sources.
54 published notesEvidence notes
Open
2026-07-172 min
GHRP-6: Animal-to-Human Translation and Evidence Boundaries
An evidence-led GHRP-6 review focused on animal-to-human translation, human-study limits, regulatory context and claim verification.
Reviewed by Endocrine Evidence Desk2026-07-172 min
GHRP-6: Combination Evidence Test and Evidence Boundaries
An evidence-led GHRP-6 review focused on combination evidence test, human-study limits, regulatory context and claim verification.
Reviewed by Endocrine Evidence Desk2026-07-152 min
GHRP-6: Safety Signal Review and Evidence Boundaries
An evidence-led GHRP-6 review focused on safety signal review, human-study limits, regulatory context and claim verification.
Reviewed by Endocrine Evidence Desk2026-07-132 min
Sermorelin: Research Gaps Map and Evidence Boundaries
An evidence-led Sermorelin review focused on research gaps map, human-study limits, regulatory context and claim verification.
Reviewed by Endocrine Evidence Desk2026-07-122 min
Sermorelin: Adverse-Event Reporting and Evidence Boundaries
An evidence-led Sermorelin review focused on adverse-event reporting, human-study limits, regulatory context and claim verification.
Reviewed by Endocrine Evidence Desk2026-07-112 min
Sermorelin: Sampling and Assay Timing and Evidence Boundaries
An evidence-led Sermorelin review focused on sampling and assay timing, human-study limits, regulatory context and claim verification.
Reviewed by Endocrine Evidence Desk2026-07-092 min
Sermorelin: Endpoint Hierarchy and Evidence Boundaries
An evidence-led Sermorelin review focused on endpoint hierarchy, human-study limits, regulatory context and claim verification.
Reviewed by Endocrine Evidence Desk2026-07-082 min
Sermorelin: Human Trial Design and Evidence Boundaries
An evidence-led Sermorelin review focused on human trial design, human-study limits, regulatory context and claim verification.
Reviewed by Endocrine Evidence Desk